FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894096031> ?p ?o ?g. }

• W2894096031 endingPage "3245" @default.
• W2894096031 startingPage "3235" @default.
• W2894096031 abstract "Ongoing studies of physiological and pathological processes have led to a corresponding need for new radiopharmaceuticals, especially when studies are limited by the absence of a particular radiolabeled target. Thus, the development of new radioactive tracers is highly relevant and can represent a significant contribution to efforts to elucidate important phenomena in biology. Currently, theranostics represents a new frontier in the fields of medicine and nuclear medicine, with the same compound being used for both diagnosis and treatment. In the human body, copper (Cu) is the third most abundant metal and it plays a crucial role in many biological functions. Correspondingly, in various acquired and inherited pathological conditions, such as cancer and Alzheimer's disease, alterations in Cu levels have been found. Moreover, a wide spectrum of neurodegenerative disorders are associated with higher or lower levels of Cu, as well as inappropriately bound or distributed levels of Cu in the brain. In human cells, the membrane protein, hCtr1, binds Cu in its Cu(I) oxidation state in an energy-dependent manner. Copper-64 (64Cu) is a cyclotron-produced radionuclide that has exhibited physical properties that are complementary for diagnosis and/or therapeutic purposes. To date, very few reports have described the clinical development of 64Cu as a radiotracer for cancer imaging. In this review, we highlight recent insights in our understanding and use of 64CuCl2 as a theranostic agent for various types of tumors. To the best of our knowledge, no adverse effects or clinically observable pharmacological effects have been described for 64CuCl2 in the literature. Thus, 64Cu represents a revolutionary radiopharmaceutical for positron emission tomography imaging and opens a new era in the theranostic field." @default.
• W2894096031 created "2018-10-05" @default.
• W2894096031 creator A5011343653 @default.
• W2894096031 creator A5029804901 @default.
• W2894096031 creator A5088890340 @default.
• W2894096031 date "2018-10-01" @default.
• W2894096031 modified "2023-10-13" @default.
• W2894096031 title "Copper-64: a real theranostic agent" @default.
• W2894096031 cites W1522796258 @default.
• W2894096031 cites W1597055088 @default.
• W2894096031 cites W1600667496 @default.
• W2894096031 cites W1764864075 @default.
• W2894096031 cites W1788773500 @default.
• W2894096031 cites W1816878569 @default.
• W2894096031 cites W1973860724 @default.
• W2894096031 cites W1978301936 @default.
• W2894096031 cites W1978952912 @default.
• W2894096031 cites W1980443589 @default.
• W2894096031 cites W1987004867 @default.
• W2894096031 cites W1987133102 @default.
• W2894096031 cites W2011095090 @default.
• W2894096031 cites W2037077450 @default.
• W2894096031 cites W2040655140 @default.
• W2894096031 cites W2052987925 @default.
• W2894096031 cites W2074709818 @default.
• W2894096031 cites W2079813006 @default.
• W2894096031 cites W2080493328 @default.
• W2894096031 cites W2082140093 @default.
• W2894096031 cites W2088549024 @default.
• W2894096031 cites W2092780067 @default.
• W2894096031 cites W2094146747 @default.
• W2894096031 cites W2096831642 @default.
• W2894096031 cites W2099090110 @default.
• W2894096031 cites W2099715775 @default.
• W2894096031 cites W2103832652 @default.
• W2894096031 cites W2105230577 @default.
• W2894096031 cites W2106044548 @default.
• W2894096031 cites W2109928864 @default.
• W2894096031 cites W2111770719 @default.
• W2894096031 cites W2112062385 @default.
• W2894096031 cites W2115141253 @default.
• W2894096031 cites W2117437668 @default.
• W2894096031 cites W2119501925 @default.
• W2894096031 cites W2126798905 @default.
• W2894096031 cites W2134077541 @default.
• W2894096031 cites W2143768506 @default.
• W2894096031 cites W2144287351 @default.
• W2894096031 cites W2156987617 @default.
• W2894096031 cites W2167623148 @default.
• W2894096031 cites W2177559000 @default.
• W2894096031 cites W2189502301 @default.
• W2894096031 cites W2335447300 @default.
• W2894096031 cites W2398038094 @default.
• W2894096031 cites W2398695997 @default.
• W2894096031 cites W2466852313 @default.
• W2894096031 cites W2471588702 @default.
• W2894096031 cites W2523233937 @default.
• W2894096031 cites W2528538089 @default.
• W2894096031 cites W2534848937 @default.
• W2894096031 cites W2581434288 @default.
• W2894096031 cites W2617757390 @default.
• W2894096031 cites W2746673367 @default.
• W2894096031 cites W2772744872 @default.
• W2894096031 cites W2784493975 @default.
• W2894096031 cites W2790966028 @default.
• W2894096031 cites W3089349423 @default.
• W2894096031 doi "https://doi.org/10.2147/dddt.s170879" @default.
• W2894096031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6173185" @default.
• W2894096031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30323557" @default.
• W2894096031 hasPublicationYear "2018" @default.
• W2894096031 type Work @default.
• W2894096031 sameAs 2894096031 @default.
• W2894096031 citedByCount "60" @default.
• W2894096031 countsByYear W28940960312020 @default.
• W2894096031 countsByYear W28940960312021 @default.
• W2894096031 countsByYear W28940960312022 @default.
• W2894096031 countsByYear W28940960312023 @default.
• W2894096031 crossrefType "journal-article" @default.
• W2894096031 hasAuthorship W2894096031A5011343653 @default.
• W2894096031 hasAuthorship W2894096031A5029804901 @default.
• W2894096031 hasAuthorship W2894096031A5088890340 @default.
• W2894096031 hasBestOaLocation W28940960311 @default.
• W2894096031 hasConcept C121608353 @default.
• W2894096031 hasConcept C126322002 @default.
• W2894096031 hasConcept C169760540 @default.
• W2894096031 hasConcept C171250308 @default.
• W2894096031 hasConcept C185592680 @default.
• W2894096031 hasConcept C192562407 @default.
• W2894096031 hasConcept C60644358 @default.
• W2894096031 hasConcept C70721500 @default.
• W2894096031 hasConcept C71924100 @default.
• W2894096031 hasConcept C86803240 @default.
• W2894096031 hasConceptScore W2894096031C121608353 @default.
• W2894096031 hasConceptScore W2894096031C126322002 @default.
• W2894096031 hasConceptScore W2894096031C169760540 @default.
• W2894096031 hasConceptScore W2894096031C171250308 @default.
• W2894096031 hasConceptScore W2894096031C185592680 @default.
• W2894096031 hasConceptScore W2894096031C192562407 @default.

• next